Tag Archive for: CD3
Project Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
177Lu-PSMA-617 225Ac abiraterone abiraterone acetate ADC ADT ai in healthcare antibody-drug conjugate apalutamide ATM B7-H3 bispecific antibody bone metastases bone metastasis BRCA BRCA2 cancer immunotherapy CAR-T CD3 clinical trial crispr darolutamide docetaxel drug repurposing enzalutamide EZH2 inhibitor HRR immunotherapy mcrpc mHSPC mRNA NEPC neuroendocrine prostate cancer oncolytic virus PARP1 PARP inhibitor Pluvicto prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data STEAP1 T-cell therapy
Latest Posts
- Aglatimagene Besadenovec (CAN-2409): Phase 3 Benefit Now Backed by Evidence of Lasting Immune Remodeling October 1, 2026
- ATM-Altered Prostate Cancer May Be Especially Sensitive to Lu-177-PSMA October 1, 2026
- TTX-MC138 Takes Aim at a Master MicroRNA September 30, 2026
- Phase 2/3 Trial For 68Ga-DOTA-RM2: GRPR-Targeted PET Could Open the Door to a New Theranostic Platform September 30, 2026